Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.

Roy HK, Turzhitsky V, Wali R, Radosevich AJ, Jovanovic B, Della'Zanna G, Umar A, Rubin DT, Goldberg MJ, Bianchi L, De La Cruz M, Bogojevic A, Helenowski IB, Rodriguez L, Chatterton R, Skripkauskas S, Page K, Weber CR, Huang X, Richmond E, Bergan RC, Backman V.

Gut. 2017 Feb;66(2):285-292. doi: 10.1136/gutjnl-2015-309996. Epub 2015 Oct 26.

2.

Tissue-specific patterns of gene expression in the epithelium and stroma of normal colon in healthy individuals in an aspirin intervention trial.

Thomas SS, Makar KW, Li L, Zheng Y, Yang P, Levy L, Rudolph RY, Lampe PD, Yan M, Markowitz SD, Bigler J, Lampe JW, Potter JD.

BMC Med Genet. 2015 Mar 24;16:18. doi: 10.1186/s12881-015-0161-6.

3.

The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions.

Angstadt AY, Hartman TJ, Lesko SM, Muscat JE, Zhu J, Gallagher CJ, Lazarus P.

Genes Chromosomes Cancer. 2014 Jun;53(6):454-66.

4.

Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry.

Scherer D, Koepl LM, Poole EM, Balavarca Y, Xiao L, Baron JA, Hsu L, Coghill AE, Campbell PT, Kleinstein SE, Figueiredo JC, Lampe JW, Buck K, Potter JD, Kulmacz RJ, Jenkins MA, Hopper JL, Win AK, Newcomb PA, Ulrich CM, Makar KW.

Genes Chromosomes Cancer. 2014 Jul;53(7):568-78. doi: 10.1002/gcc.22167. Epub 2014 Mar 28.

5.

Statistical tests for detecting associations with groups of genetic variants: generalization, evaluation, and implementation.

Ferguson J, Wheeler W, Fu Y, Prokunina-Olsson L, Zhao H, Sampson J.

Eur J Hum Genet. 2013 Jun;21(6):680-6. doi: 10.1038/ejhg.2012.220. Epub 2012 Oct 24.

6.

UGT1A6 polymorphisms modulated lung cancer risk in a Chinese population.

Kua LF, Ross S, Lee SC, Mimura K, Kono K, Goh BC, Yong WP.

PLoS One. 2012;7(8):e42873. doi: 10.1371/journal.pone.0042873. Epub 2012 Aug 17.

7.

The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma.

Chan AT, Hsu M, Zauber AG, Hawk ET, Bertagnolli MM.

Cancer Prev Res (Phila). 2012 Jan;5(1):61-72. doi: 10.1158/1940-6207.CAPR-11-0337. Epub 2011 Oct 26.

8.

Intracellular erythrocyte platelet-activating factor acetylhydrolase I inactivates aspirin in blood.

Zhou G, Marathe GK, Willard B, McIntyre TM.

J Biol Chem. 2011 Oct 7;286(40):34820-9. doi: 10.1074/jbc.M111.267161. Epub 2011 Aug 15.

9.

Association of stem-like cells in gender-specific chemoprevention against intestinal neoplasia in MIN mouse.

Gandhi SR, Tiwari AK, Kunte DP, De la Cruz MA, Stypula Y, Gibson T, Brasky J, Backman V, Wali RK, Roy HK.

Oncol Rep. 2011 Nov;26(5):1127-32. doi: 10.3892/or.2011.1395. Epub 2011 Jul 18.

10.

Determinants of aspirin metabolism in healthy men and women: effects of dietary inducers of UDP-glucuronosyltransferases.

Navarro SL, Saracino MR, Makar KW, Thomas SS, Li L, Zheng Y, Levy L, Schwarz Y, Bigler J, Potter JD, Lampe JW.

J Nutrigenet Nutrigenomics. 2011;4(2):110-8. doi: 10.1159/000327782. Epub 2011 May 28.

11.

Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk.

Pinheiro SP, Gates MA, De Vivo I, Rosner BA, Tworoger SS, Titus-Ernstoff L, Hankinson SE, Cramer DW.

Int J Mol Epidemiol Genet. 2010 Sep 3;1(4):320-31.

12.

Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial.

Johnson CC, Hayes RB, Schoen RE, Gunter MJ, Huang WY; PLCO Trial Team.

Am J Gastroenterol. 2010 Dec;105(12):2646-55. doi: 10.1038/ajg.2010.349. Epub 2010 Aug 31.

13.

Primary prevention of colorectal cancer.

Chan AT, Giovannucci EL.

Gastroenterology. 2010 Jun;138(6):2029-2043.e10. doi: 10.1053/j.gastro.2010.01.057. Review.

14.

No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.

Thompson CL, Plummer SJ, Merkulova A, Cheng I, Tucker TC, Casey G, Li L.

World J Gastroenterol. 2009 May 14;15(18):2240-4.

15.

C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps.

Poole EM, Bigler J, Whitton J, Sibert JG, Potter JD, Ulrich CM.

Pharmacogenet Genomics. 2009 Feb;19(2):113-20. doi: 10.1097/FPC.0b013e32831bd976.

16.

UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans.

Girard H, Butler LM, Villeneuve L, Millikan RC, Sinha R, Sandler RS, Guillemette C.

Mutat Res. 2008 Sep 26;644(1-2):56-63. doi: 10.1016/j.mrfmmm.2008.07.002. Epub 2008 Jul 16.

17.

UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers.

Limenta LM, Jirasomprasert T, Tankanitlert J, Svasti S, Wilairat P, Chantharaksri U, Fucharoen S, Morales NP.

Br J Clin Pharmacol. 2008 Jun;65(6):908-16. doi: 10.1111/j.1365-2125.2008.03103.x. Epub 2008 Mar 3.

18.

A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.

Cross JT, Poole EM, Ulrich CM.

Pharmacogenomics J. 2008 Aug;8(4):237-47. doi: 10.1038/sj.tpj.6500487. Epub 2008 Jan 15. Review.

19.

Aspirin dose and duration of use and risk of colorectal cancer in men.

Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS.

Gastroenterology. 2008 Jan;134(1):21-8. Epub 2007 Sep 26.

20.

Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis.

Hisamuddin IM, Wehbi MA, Schmotzer B, Easley KA, Hylind LM, Giardiello FM, Yang VW.

Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2366-9.

Supplemental Content

Support Center